Scientific Reports · 2015 · 26 citations · 39 references
Life SciencesNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationMethylene Blue TherapyNeurodegenerative DiseasesNeurodegenerative DisordersReactive Oxygen SpeciesReactive Oxygen Species BiologyTau PathologyNeurologic DeficitsPhotosensitive MaterialsSinglet Oxygen GenerationTau Pathology ModulationTau ToxicityTau-associated NeurodegenerationTau-targeted TherapyTauopathy Models
Methylene blue (MB) inhibits the aggregation of tau, a main constituent of neurofibrillary tangles. However, MB's mode of action in vivo is not fully understood. MB treatment reduced the amount of sarkosyl-insoluble tau in Drosophila that express human wild-type tau. MB concurrently ameliorated the climbing deficits of transgenic tau flies to a limited extent and diminished the climbing activity of wild-type flies. MB also decreased the survival rate of wild-type flies. Based on its photosensitive efficacies, we surmised that singlet oxygen generated through MB under light might contribute to both the beneficial and toxic effects of MB in vivo. We identified rose bengal (RB) that suppressed tau accumulation and ameliorated the behavioral deficits to a lesser extent than MB. Unlike MB, RB did not reduce the survival rate of flies. Our findings indicate that singlet oxygen generators with little toxicity may be suitable drug candidates for treating tauopathies.
39
NIH Image to ImageJ: 25 years of image analysis
Caroline A Schneider, Wayne Rasband, Kevin W. Eliceiri · Nature Methods · 2012 · 65.2K citations
Tauopathy in <i>Drosophila</i> : Neurodegeneration Without Neurofibrillary Tangles
Curtis W. Wittmann, Matthew Wszolek, Joshua M. Shulman et al. · Science · 2001 · 943 citations
Genetic dissection of consolidated memory in Drosophila
Tim Tully, Thomas Préat, S Boynton et al. · Cell · 1994 · 942 citations